![](https://unicorn-nest.com/wp-content/uploads/avatars/funds/fund_pfizer_breakthrough_growth_initiative.jpg?x55332)
Related Funds
Fund Name | Location |
Aegon Capital Management | Canada, Ontario, Toronto |
Alsthom industries | - |
Amesto Solutions | Norway, Oslo |
BENE Asia Capital | - |
CheckAlt | - |
CHINA.COM | Beijing, Beijing, China |
Concrete Ventures | Canada, Halifax, Nova Scotia |
Frontive Holding Limited | - |
German Federal Ministry of Education and Research (BMBF) | Bonn, Germany, Nordrhein-Westfalen |
GunnAllen Venture Partners | Florida, Tampa, United States |
InCrowd Capital | Nashville, Tennessee, United States |
North Star Equity Investment Partners | - |
Numenor Ventures | California, Santa Barbara, United States |
RP Partners | California, Los Angeles, United States |
SeriesG | California, San Francisco, United States |
SparkLabs Taipei | New Taipei, Taiwan |
Stylebread | Hokkaido, Hokkaido Prefecture, Japan |
Tera Capital Corporation | Canada, Ontario, Toronto |
TR Aeroventures | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Cour Pharmaceuticals Development | $105M | 30 Jan 2024 | Elmhurst, Illinois, United States | ||
AgomAb Therapeutics | $45M | 13 Jul 2022 | Ghent, East Flanders, Belgium |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Cour Pharmaceuticals Development | $105M | 30 Jan 2024 | Elmhurst, Illinois, United States | ||
AgomAb Therapeutics | $45M | 13 Jul 2022 | Ghent, East Flanders, Belgium |